Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxtellar XR in Trigeminal Neuralgia
NCT03374709Phase 4Withdrawn
- Sponsor
- University of Colorado Denver
- Start
- Dec 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of oxcarbazepine in trigeminal neuralgia (TN), sponsored by University of Colorado Denver. Planned start Dec 2018; status: withdrawn.
02
Drugs
oxcarbazepine
03
Conditions
trigeminal neuralgia (TN)
Beyond the preview
Go deeper on NCT03374709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03374709.